Eye blood vessel width may indicate coronary heart death riskJuly 13, 2006Retinal vascular calibre and the risk of coronary heart disease related health Online First Heart 2006; doi:101136/hrt.2006.090522 The calibre of the small veins and arteries in the eye may be a good indicator of a middle aged person's chances of dying from coronary heart disease, suggests research published ahead of print in Heart. The researchers analysed the calibre of the vasculature of the retina in more than 3600 men and women over the age of 49. This was done by looking at detailed photographs of the back of the eye, measuring the diameters of the small arteries (arterioles) and small veins (venules), and calculating their ratio, known as the AVR. Arterioles and venules are small branches of main arteries and veins, and their condition reflects the general state of the smaller blood vessels in the body, or microcirculation. During the nine years of the study, 78 women (just over 4%) and 114 men (just under 8%) died from coronary heart disease. Among those aged 49 and up to the age of 75, although relatively uncommon, deaths from coronary heart disease doubled if the venules were wider. Wider venules have been linked to several risk factors for coronary heart disease, including smoking, systemic inflammation, high total cholesterol and obesity. In women in this age narrower arterioles were also associated with a 50% increased risk of dying from coronary heart disease. The authors point out that the numbers involved are small, as fewer people die from heart disease. But signs in the small vessels of the eye appear to be independent predictors of the risk of death from coronary heart disease among those under 75, particularly in women. Retinal photography may be a useful non-invasive method of assessing this risk, they suggest. BMJ Specialty Journals |
|||||||||||||||||||||
| Related Coronary Heart Disease Current Events and Coronary Heart Disease News Articles ESC to give talks on Diabetes in three cities in China As a result of successful events organised last year, a second Joint Scientific Forum, organised by the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), two of the most respected professional medical organisations in Europe, will be held from 27-29 November at three venues across China - Beijing, Shanghai and Guangzhou. Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. oo much selenium can increase your cholesterol A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost 10%. Postmenopausal women with higher testosterone levels Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels. Study points to new uses, unexpected side effects of already-existing drugs Scientists at the University of North Carolina at Chapel Hill School of Medicine and the University of California, San Francisco have developed and experimentally tested a technique to predict new target diseases for existing drugs. Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. Adding ezetimibe to atorvastatin improves lipid control Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone. Learning the risks for stroke - and taking action With this theme in mind, the European Society of Cardiology (ESC) emphasises that most of the risks for stroke are also the major risks for coronary heart disease - and thus the object of the ESC's far-reaching prevention programme. South Asian Canadians failing to get exercise message Exercise is a wonderful way of boosting heart health, but it's proving to be a tough sell in Ontario South Asian communities, Dr. Milan Gupta told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. Grains and lamb offer new sources of omega-3 CSIRO research on grains and lamb aimed at developing new dietary sources of long-chain omega-3 oils will be presented at the World Congress on Oils and Fats in Sydney this week. More Coronary Heart Disease Current Events and Coronary Heart Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||